GH treatment in neonates

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 4, 1996, Pages 398-400

  Wollmann, H A ^a   Ranke, M B ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

DRUG EFFECT; HUMAN; INTRAUTERINE GROWTH RETARDATION; NEWBORN; NOTE; PREMATURITY; PRIORITY JOURNAL;

EID: 0029965888     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14047.x     Document Type: Note

References (17)

1. 1 Hack M. The outcome of neonatal intensive care. In: Klaus MH, Fanaroff AA, editors. Care of the high‐risk neonate. 4th ed., Philadelphia: WB Saunders, 1993 ; 456–63.
2. 2 Chard T. Insulin‐like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul 1994 ; 4: 91–100.
3. 3 DeChiara TM, Efstratiadis A, Robertson EJ. A growth‐deficiency phenotype in heterozygous mice carrying an insulin‐like growth factor II gene disrupted by targeting. Nature 1990 ; 345: 78–80.
4. 4 Gluckman PD. The endocrine regulation of fetal growth in late potation: The role of insulin‐like growth factors. J Clin Endocrinol Metab 1995 ; 80: 1047–50.
5. 5 Fowden AL. Insulin deficiency: effects on fetal growth and development. J Paediatr Child Health 1993 ; 29: 6–11.
6. 6 Gluckman PD. Growth hormone deficienca diagnosed and treated in the first 2 years of life: evidence ot the role of growth hormone in human perinatal growth. In: Ranke MB, Gunnarsson R, editors. Progress in growth hormone therapy‐5 years of KIGS. Mannheim: JJ Verlag 1994 ; 88–96.
7. 7 de Zegher F, Kimpen J, Raus J. Vanderschueren‐Lodeweyckx M. Hypersomatotropism in the dysmature infant at term and preterm birth. Biol Neonate 1990 ; 58: 188–91.
8. 8 van Toledo‐Eppinga L, Houdijk ECAM, Cranendonk A, Delemarre‐Van de Waal HA, Lafeber H. Erects of recombinant human growth hormone treatment in intrauterine growth‐retarded preterm newborn infants on growth. body composition and energy expenditure. Acta Paediatr 1996 ; 85: 476–81.
9. 9 Sheng HP, Muthappa PR, Wong WW, Schanler RJ. Pitfalls of body fat assessments in premature infants ny anthropometry. Biol Neonate 1993 ; 64: 279–86.
10. 10 de Bruin N, Westerterp KR, Degenhart HJ, Visser HKA. Measurement of fat‐free mass in infants. Pediatr Res 1995 ; 38: 411–7.
11. 11 Robinson D, Weiner CP, Nakamura KT, Robillard JE. Effect of intrauterine growth retardation on renal function on day one of life. Am J Perinatol 1990 ; 7: 343–8.
12. 12 Michaelsen KF, Skov L, Badsberg JH, Jörgensen M. Short‐term measurement of linear growth in preterm infants: validation of a hand‐held knemometer. Pediatr Res 1991 ; 30: 464–8.
13. 13 Wollmann HA, Ranke MB. Metabolic erects of growth hormone in children. Metabolism 1995 ; 10: Suppl 4: 97–102.
14. 14 Clark DA. Nutritional requirements of the premature ad small for gestational age infant. In: Suskind RM, Lewinter‐Suskind L, editors. Textbook of pediatric nutrition. New York: Raven Press, 1992 ; 23–32.
15. 15 Barker DJP. The intrauterine origins of cardiovascular disease. Acta Paediatr Suppl 1993 ; 391: 93–9.
16. 16 Husain MA, Schmitz O, Mengel A, Glatz Y, Christiansen JS, Zapf J, Froesch ER. Comparison of the effects of growth hormone and insulin‐like growth factor I on substrate oxidation and insulin sensitivity in growth hormone‐deficient humans. J Clin Invest 1994 ; 94: 1126–33.
17. 17 Rosenfeld RG, Bentsson BA. Effects of growth hormone and insulin‐like growth factors on the central nervous system. Acta Paediatr Suppl 1994 ; 406: 89–91.